Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,774 public trials 698 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Recruiting

Prevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With Diffuse Large-B Cell Lymphoma

NCT06220032

Conditions
Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +22 more
Locations
  • NL-Den Bosch-JBZ 's-Hertogenbosch, Netherlands
  • NL-Almelo-ZGTALMELO Almelo, Netherlands
  • NL-Amstelveen-AMSTELLAND Amstelveen, Netherlands
  • NL-Apeldoorn-GELREAPELDOORN Apeldoorn, Netherlands
View all 25 locations
View Trial Details
Recruiting

Extracorporeal Photopheresis in Sezary Syndrome

NCT05157581

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Emory University School of Medicine Atlanta, Georgia, United States
  • Cutaneous Translational Research Program - Johns Hopkins Medicine Baltimore, Maryland, United States
  • University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
View Trial Details
Recruiting

Exploring the Clinical Impact of MYC Aberrations and Their Relationship With Microenvironment in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma

NCT06588205

Conditions
Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, +11 more
Locations
  • A.O.U. SS. Antonio e Biagio e C. Arrigo - S.C.D.U. Ematologia Alessandria, Italy
  • A.O.U. Ospedali Riuniti delle Marche - Clinica di Ematologia Ancona, Italy
  • I.R.C.C.S. Istituto Tumori Giovanni Paolo II - U.O.C. Ematologia Bari, Italy
  • ASST Spedali Civili - S.C. Ematologia Brescia, Italy
View all 20 locations
View Trial Details
Recruiting

Multilayer Biological Characterization of Advanced Follicular Lymphoma: a Translational Study From FIL_FOLL12 Trial

NCT05816850

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • A.O. SS. Antonio e Biagio e Cesare Arrigo, S.C. Ematologia Alessandria, Italy
  • Nuovo Ospedale degli Infermi, SSD Ematologia Biella, Italy
  • ASST Spedali Civili di Brescia - Ematologia Brescia, Italy
  • Azienda Ospedaliera Universitaria Policlinico - S. Marco, UOC di Ematologia Catania, Italy
View all 26 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Relapsed/ Refractory B-Cell Non-Hodgkin Lymphoma

NCT06392477

Conditions
B-cell Non Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Investigational Site Number : 001-203 Camperdown, New South Wales, Australia
  • Investigational Site Number : 001-202 Townsville, Queensland, Australia
  • Investigational Site Number : 001-205 Adelaide, South Australia, Australia
  • Investigational Site Number : 001-204 Melbourne, Victoria, Australia
View all 16 locations
View Trial Details
Recruiting

A Study in Leukemia Patients With Karonudib

NCT04077307

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations
  • Aarhus University Hospital Aarhus, Denmark
  • Rigshospitalet Copenhagen University Hospital Copenhagen, Denmark
  • University Clinical Center Belgrade Belgrade, Serbia
  • University Clinical Center Kragujevac Kragujevac, Serbia
View Trial Details

Related conditions